X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (375) 375
infectious diseases (250) 250
female (230) 230
index medicus (209) 209
immunology (203) 203
male (199) 199
virology (183) 183
adult (161) 161
hiv infections - drug therapy (158) 158
viral load (155) 155
hiv infections - virology (152) 152
microbiology (152) 152
hiv (148) 148
hiv infections - immunology (105) 105
hiv-1 (99) 99
human immunodeficiency virus--hiv (93) 93
life sciences (93) 93
antiretroviral therapy (88) 88
hiv-1 - genetics (87) 87
aids (85) 85
disease progression (83) 83
middle aged (80) 80
infection (77) 77
anti-hiv agents - therapeutic use (74) 74
hiv infection (73) 73
cd4 lymphocyte count (72) 72
biochemistry (70) 70
chemistry (68) 68
infections (68) 68
pregnancy (68) 68
antiretroviral drugs (67) 67
beer (67) 67
enzymology (67) 67
hiv-1 - isolation & purification (67) 67
infant (67) 67
metallurgy (67) 67
mutation or genetic engineering (67) 67
spirits (67) 67
vinegar (67) 67
wine (67) 67
rna, viral - blood (65) 65
rna (62) 62
cohort studies (60) 60
human-immunodeficiency-virus (60) 60
research (60) 60
aids/hiv (59) 59
drug therapy (59) 59
health aspects (58) 58
dna (57) 57
infant, newborn (57) 57
peptides (57) 57
organic chemistry (56) 56
compositions or test papers therefor (55) 55
compositions thereof (55) 55
condition-responsive control in microbiological orenzymological processes (55) 55
culture media (55) 55
hiv-1 - drug effects (55) 55
hiv-1 - physiology (55) 55
immunodeficiency-virus type-1 (55) 55
measuring or testing processes involving enzymes, nucleicacids or microorganisms (55) 55
microorganisms or enzymes (55) 55
processes of preparing such compositions (55) 55
propagating, preserving or maintaining microorganisms (55) 55
treatment outcome (52) 52
physics (51) 51
testing (51) 51
virus diseases (51) 51
active antiretroviral therapy (50) 50
hiv infections - transmission (50) 50
investigating or analysing materials by determining theirchemical or physical properties (50) 50
measuring (50) 50
antiretroviral therapy, highly active (48) 48
hiv-1 - immunology (48) 48
highly active antiretroviral therapy (46) 46
human necessities (46) 46
hygiene (46) 46
medical or veterinary science (46) 46
preparations for medical, dental, or toilet purposes (46) 46
hiv infections (44) 44
antiviral agents (41) 41
child, preschool (41) 41
prospective studies (41) 41
adolescent (40) 40
child (40) 40
viruses (40) 40
human immunodeficiency virus (39) 39
hiv infections - epidemiology (38) 38
acquired immune deficiency syndrome--aids (37) 37
children (37) 37
deoxyribonucleic acid--dna (37) 37
lymphocytes (37) 37
anti-hiv agents - administration & dosage (36) 36
cd4-positive t-lymphocytes - immunology (36) 36
cd8-positive t-lymphocytes - immunology (36) 36
hiv 1 (36) 36
time factors (36) 36
transmission (36) 36
risk factors (35) 35
dna, viral - blood (34) 34
drug therapy, combination (34) 34
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biofutur, ISSN 0294-3506, 05/2013, Issue 343, pp. 60 - 62
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9883, pp. 2109 - 2117
Journal Article
Retrovirology, ISSN 1742-4690, 04/2018, Volume 15, Issue 1, pp. 30 - 7
Journal Article
Bulletin de l'Academie Nationale de Medecine, ISSN 0001-4079, 09/2018, Volume 202, Issue 7, pp. 1413 - 1420
Journal Article
PLoS Pathogens, ISSN 1553-7366, 2013, Volume 9, Issue 3, p. e1003211
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 4, pp. 387 - 396
Journal Article
PLoS Pathogens, ISSN 1553-7366, 07/2015, Volume 11, Issue 7, p. e1005063
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2009, Volume 119, Issue 4, pp. 997 - 1007
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2012, Volume 54, Issue 9, pp. 1348 - 1360
Background. The association between combination antiretroviral (cARV) therapy use by human immunodeficiency virus (HIV)—infected women during pregnancy and... 
Pregnancy | HIV/AIDS | Antiretrovirals | HIV | Protease inhibitors | Memory interference | Premature birth | Preeclampsia | Predisposing factors | AIDS | Obstetric labor complications | PRETERM DELIVERY | INFECTIOUS DISEASES | LOW-BIRTH-WEIGHT | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | PREECLAMPSIA | IMMUNOLOGY | TRANSMISSION | INCREASED RISK | INFANTS | DYSFUNCTION | EXPOSURE | HAART | Pregnancy Complications, Infectious - virology | Humans | Incidence | Reverse Transcriptase Inhibitors - adverse effects | Ritonavir - adverse effects | Premature Birth - chemically induced | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Infant, Newborn | HIV Protease Inhibitors - adverse effects | France - epidemiology | Zidovudine - adverse effects | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Premature Birth - epidemiology | HIV Protease Inhibitors - therapeutic use | Premature Birth - etiology | Infant, Premature | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Cohort Studies | Usage | Pregnant women | Ritonavir | Research | HIV (Viruses) | Health aspects
Journal Article
PLoS Pathogens, ISSN 1553-7366, 2015, Volume 11, Issue 9, p. e1005153
Two of the crucial aspects of human immunodeficiency virus (HIV) infection are (i) viral persistence in reservoirs (precluding viral eradication) and (ii)... 
LONG-TERM NONPROGRESSORS | MESSENGER-RNA EXPRESSION | MICROBIOLOGY | NECROSIS-FACTOR-ALPHA | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN ADIPOCYTES | VIROLOGY | ACTIVE ANTIRETROVIRAL THERAPY | SIVMAC251 INFECTION | IMMUNE ACTIVATION | METABOLIC-DISORDERS | MEMORY T-CELLS | PARASITOLOGY | Simian Acquired Immunodeficiency Syndrome - metabolism | HIV - physiology | Stromal Cells - pathology | Coculture Techniques | Humans | Middle Aged | Macaca fascicularis | Male | HIV - immunology | Adipose Tissue - immunology | CD4-Positive T-Lymphocytes - pathology | CD4-Positive T-Lymphocytes - immunology | Simian Immunodeficiency Virus - isolation & purification | Adipose Tissue - metabolism | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Macrophages - virology | HIV Infections - pathology | Stromal Cells - virology | Adult | Female | Panniculitis - immunology | Disease Reservoirs | CD4-Positive T-Lymphocytes - virology | Simian Acquired Immunodeficiency Syndrome - pathology | Macrophages - immunology | Simian Immunodeficiency Virus - immunology | Macrophages - pathology | Adipose Tissue - virology | HIV Infections - virology | Stromal Cells - metabolism | Adipose Tissue - pathology | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Stromal Cells - immunology | HIV - isolation & purification | Immunity, Innate | Panniculitis - virology | Simian Immunodeficiency Virus - physiology | Host-Pathogen Interactions | Macrophages - metabolism | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Aged | Panniculitis - pathology | Panniculitis - metabolism | HIV Infections - metabolism | Adipose tissues | Host-virus relationships | HIV (Viruses) | Simian immunodeficiency virus | Observations | Health aspects | Life Sciences | Human health and pathology | Antiretroviral drugs | Lymphatic system | Mortality | Infections | Inflammation | Adipocytes | Metabolism | Experiments | HIV | Lymphocytes | Rodents | Deoxyribonucleic acid | DNA | Human immunodeficiency virus | Drug therapy
Journal Article